Caitlin Cronin
Stock Analyst at Canaccord Genuity
(0.33)
# 3,148
Out of 4,413 analysts
7
Total ratings
n/a
Success rate
-8.88%
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATEC Alphatec Holdings | Reiterates: Buy | $25 | $12.97 | +92.75% | 1 | Mar 20, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Hold | $130 | $119.56 | +8.73% | 1 | Feb 23, 2024 | |
| ENOV Enovis | Maintains: Buy | $73 → $75 | $55.40 | +35.38% | 1 | Feb 23, 2024 | |
| INMD InMode | Reiterates: Hold | $22 | $17.24 | +27.61% | 1 | Dec 7, 2023 | |
| AXGN AxoGen | Reiterates: Buy | $11 | $6.56 | +67.68% | 1 | Dec 7, 2023 | |
| KRMD KORU Medical Systems | Reiterates: Buy | $3 | $2.25 | +33.33% | 1 | Dec 7, 2023 | |
| RBOT Vicarious Surgical | Downgrades: Hold | $9 → $0.4 | $0.28 | +42.35% | 1 | Nov 14, 2023 |
Alphatec Holdings
Mar 20, 2024
Reiterates: Buy
Price Target: $25
Current: $12.97
Upside: +92.75%
Zimmer Biomet Holdings
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $119.56
Upside: +8.73%
Enovis
Feb 23, 2024
Maintains: Buy
Price Target: $73 → $75
Current: $55.40
Upside: +35.38%
InMode
Dec 7, 2023
Reiterates: Hold
Price Target: $22
Current: $17.24
Upside: +27.61%
AxoGen
Dec 7, 2023
Reiterates: Buy
Price Target: $11
Current: $6.56
Upside: +67.68%
KORU Medical Systems
Dec 7, 2023
Reiterates: Buy
Price Target: $3
Current: $2.25
Upside: +33.33%
Vicarious Surgical
Nov 14, 2023
Downgrades: Hold
Price Target: $9 → $0.4
Current: $0.28
Upside: +42.35%